modified a CD5-IL-15/IL15sushi CAR which secretes an IL-15/IL-15 complex, to explore its clinical effectiveness against one refractory T-cell lymphoma patient with CNS infiltration. Here, IL15 is linked to T-cell non-Hodgkin lymphoma.